Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,447 signal articles · 140 in last 24h · 154,069 total before filter · latest 1h ago
140last 24h
872last 7d
145● bullish (7d)
98● bearish (7d)
214publishers
AllMacro206Earnings108M&A125Regulatory22Product21Analyst17
✕ clear all filtersticker: AXPSentiment:bullishneutralbearishshow all (incl. clickbait)
EXCLUSIVE: Ticketplus Buys Argentina's Autoentrada as Post-IPO Expansion Strategy Takes Shape
Benzinga3d agobullish
EXCLUSIVE: Ticketplus Buys Argentina's Autoentrada as Post-IPO Expansion Strategy Takes Shape

Ticketplus Ltd. (AMEX:TP), a Latin American (Santiago, Chile-based) live-entertainment technology company, acquired Argentine ticketing company Autoentrada S.A., marking its first acquisition since its August 2026 IPO. Autoentrada Adds Scale And Local Leaderships The deal converts Autoentrada from a Ticketplus white-label partner into a full operation in Argentina, giving Ticketplus direct relationships with promoters and greater control over sales, payments, access, and analytics. The financial

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub51d agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).